Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG).
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30238900.
- Also identified by DOI 10.1016/j.ijrobp.2018.05.078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.
Medical subject headings
- Mediastinum
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Radiation Oncology